[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Microalgae Market: Segmented: By Type (Spirulina, Chlorella, Dunaliella Salina, and Others), By Application (Food and Beverage, Dietary Supplements, Pharmaceuticals, Cosmetics and Personal Care, and Others) And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032

February 2023 | 318 pages | ID: M1EA21E4B099EN
Fatpos Global

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
According to a recently published Fatpos Global study on 'Microalgae Market,' the market is segmented by material type, thickness, application, transparency, end-use industry, and geography.

The Microalgae Market grew from USD 0.98 billion in 2022 to USD 2.2 billion by 3032, exhibiting a CAGR of 7.7% during the forecast period.

In addition, the study includes supply and demand risk, market attractiveness, BPS analysis, and Porter's five force model for an in-depth examination of the industry's growth drivers and inhibitors.

This research offers company profiles of some of the major competitors in the worldwide Microalgae Market market as well as information on their current competitive environment.
  • Cyanotech Corporation
  • Cellana Inc.
  • DSM
  • Corbion
  • Algarithm
  • Algaecytes
  • Australian Spirulina
  • Algatech Ltd.
  • Lyxia
  • BASF SE
  • Kuehnle AgroSystems Inc.
  • ALGISYS Biosciences Inc.
  • Euglena Co., Ltd.
  • DIC Corporation
  • Allmicroalgae
  • Other Prominent Players
Source Fatpos Global

COVID-19 Impact on Microalgae Market

Throughout the COVID-19 epidemic, we are working nonstop to support and expand your business. We will provide you with a coronavirus impact study across industries based on our experience and knowledge to assist you in getting ready for the future.

Many industries, markets, and enterprises are under a great deal of stress as a result of the COVID-19 outbreak, which has caused significant economic suffering and uncertainty. However, by working together, the entire world can overcome these difficult times. At Fatpos Global, we strive to deliver exact market intelligence by doing in-depth research into how this pandemic will affect various industries.

We're working hard to support your company's growth and survival amid the COVID-19 epidemic. We will provide you with a coronavirus impact study across industries based on our experience and knowledge to assist you in getting ready for the future.

Market segment by Region, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The Microalgae Market report also contains an analysis on:

Microalgae Market Segments
  • By Type
    • Spirulina
    • Chlorella
    • Dunaliella Salina
    • Others
  • By Application
    • Food and Beverage
    • Dietary Supplements
    • Pharmaceuticals
    • Cosmetics and Personal Care
    • Others
Source Fatpos Global

The Microalgae Market report provides answers to the following key questions:
  • What are the key outcomes of the five forces analysis of the global?
  • Which are Trending factors influencing the market shares of the top regions across the globe?
  • What is the impact of Covid19 on the current industry?
  • What are the market opportunities and threats faced by Microalgae Market?
1 EXECUTIVE SUMMARY

2 GLOBAL MICROALGAE MARKET

2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms

3 RESEARCH METHODOLOGY

3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation

4 AVERAGE PRICING ANALYSIS

5 MACRO-ECONOMIC INDICATORS

6 MARKET DYNAMICS

6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends

7 CORRELATION & REGRESSION ANALYSIS

7.1. Correlation Matrix
7.2. Regression Matrix

8 RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE

9 RISK ANALYSIS

9.1. Demand Risk Analysis
9.2. Supply Risk Analysis

10 GLOBAL MICROALGAE MARKET ANALYSIS

10.1. Porters Five Forces
  10.1.1. Threat of New Entrants
  10.1.2. Bargaining Power of Suppliers
  10.1.3. Threat of Substitutes
  10.1.4. Rivalry
10.2. PEST Analysis
  10.2.1. Political
  10.2.2. Economic
  10.2.3. Social
  10.2.4. Technological

11 GLOBAL MICROALGAE MARKET

11.1. Market Size & forecast, 2020A-2030F
  11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

12 GLOBAL ONCOLOGY PHARMACEUTICALS MARKET: MARKET SEGMENTATION

12.1. By Regions
  12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Type: Market Share (2020-2030F)
  12.2.1. Chemotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.2. Targeted Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.3. Immunotherapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.2.4. Hormonal Therapy, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Indication: Market Share (2020-2030F)
  12.3.1. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.2. Stomach Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.3. Breast Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.4. Prostate Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.3.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By End user: Market Share (2020-2030F)
  12.4.1. Specialized cancer treatment centers, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.2. Hospitals Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
  12.4.3. Retail Pharmacies, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F

13 COMPANY PROFILE

• Cyanotech Corporation
• Cellana Inc.
• DSM
• Corbion
• Algarithm
• Algaecytes
• Australian Spirulina
• Algatech Ltd.
• Lyxia
• BASF SE
• Kuehnle AgroSystems Inc.
• ALGISYS Biosciences Inc.
• Euglena Co., Ltd.
• DIC Corporation
• Allmicroalgae
• Other Prominent Players

14 CONSULTANT RECOMMENDATION

**The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.


More Publications